...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Spike

Koo, 

You clearly didn't thoroughly read those top line data examples. The Jardiance/empagliflozin EMPA-REG Outcomes trial top line release did not state the 14% RRR. The full data release, including the 14% RRR statement came at the September 2015 EASD meeting, which came after the August 2015 top line data statement.

BearDownAZ 

Share
New Message
Please login to post a reply